Skip to content
Monday 14 September 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,697.57
+0.44%
DAX
25,440.81
-0.50%
CAC 40
8,117.78
-0.76%
STOXX 50
6,260.38
-1.02%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Friday 07 January 2022 6:15 am  |  Updated:  Thursday 06 January 2022 6:46 pm

Try, try and try again is the mantra when solving business and political dilemmas

By: Tom Tugendhat

Add as a preferred source on Google
Elizabeth Holmes Fraud Trial Continues In California
Elizabeth Holmes engaged in a multimillion-dollar scheme to defraud investors with the Theranos blood testing lab services. (Photo by Justin Sullivan/Getty Images)

In 2003, start-up fever on the West Coast of the US was like a new Gold Rush. Investors chasing ideas were throwing money in the hope of magical returns. Part of this rush was based on faith and some of the investors believed tall tales when they should have dug harder to find gold.

That year Elizabeth Holmes founded Theranos. She claimed that her technology could detect diseases with a single drop of blood. She was lying. The technology was a fraud and those who invested in her found they were investing in nothing.

John Carreyrou’s brilliant book about the company’s demise, Bad Blood, reads like a thriller. Blood samples were swapped, investors misled, tests voided. It’s a tale of dishonesty and greed that has few parallels for the mountain of cash it created. Holmes was—briefly—the first woman to become a self-made billionaire.

For some this is a lesson of capitalism’s failure—how greed trumps truth when dollars are at play. In truth, it is about more than that. It speaks about integrity and the importance of shared risk. 

In science, we have seen the death of people who have rejected vaccines because of online rumours. We’ve seen criminal damage and threats to medical teams who have tried to help. Diseases we thought long gone are coming back following dishonest campaigns to spread doubt.

In politics too integrity shapes lives, and promises unfulfilled lead to popular anger. Lies can even threaten democracies. Seeing US soldiers camped in the Capitol in Washington DC last year reminded me of those I saw sleeping in the palace at Baghdad around the same time Holmes started her career of deception.

Holmes’ conviction on four counts of fraud brings an end to that scam, and it reminds us why the truth matters and we need a culture that promotes it. To get there, we need to accept failure and move on.

Today that’s harder than ever. Every keystroke is recorded, and every statement filed so that memories live in the present and restarts are tough. That’s why we all need to think hard about what we want out of our society.

We shouldn’t expect every idea to deliver. Start-ups are difficult and founders learn every time they try. Many learn more when they fail. Their creations can change lives and employ thousands, and their failures can be steps on that road. In politics too ideas are difficult and solutions bring compromise and sometimes fail. If either were easy they would already be fixed.

That’s why culture is about all of us, and matters in all areas. Capitalism isn’t a creed, it’s a description of the way free people trade effort and exchange goods. Democracy isn’t a theology, or a voting system, but how we talk to each other and try to find common solutions that work for us all.

That’s where integrity matters because when failure comes, we need to know that we have tried to do what’s best.

A strong economy is about giving people the power to start again. Every successful entrepreneur today has a story about a venture which failed and most UK businesses don’t survive the first five years. If we want more success, we need to punish dishonesty, but accept failure.

Read more

How the NHS backlog fuelled a private equity gold rush in UK health market

Private health insurance admissions continue to surge

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • Opinion

Categories

  • Opinion

Trending Articles

  • Wetherspoon boss: ‘Not up to Burnham’ to choose who is on the high street 

  • Revolut facing extortion threat after hackers steal customers’ data

  • Former Formula 1 champion loses £1.4m HMRC tax bill appeal

  • Reform hits back at Tory plan to ‘abolish inheritance tax’

  • Four interest rate hikes loom despite surprise economic growth

More from Morning Wire

  • How the NHS backlog fuelled a private equity gold rush in UK health market

    Healthcare
    Private health insurance admissions continue to surge
  • Investors fret as UK fintech chief bows out

    Fintech
    Woman in purple shirt speaking at a podium with Funding Circle logo on the wall
  • Football multi-club ownership firm seeks London Stock Exchange bond issue

    Sport Business
    Man views London Stock Exchange screen displaying stock prices, Fallers list, and financial data.
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • Why investors shouldn’t rush to buy the next blockbuster IPO

    Opinion
    Excited executives celebrating a SpaceX IPO at Nasdaq with confetti falling and fists raised
  • As it happened: FTSE 100 waivers; oil nears $100 on new Hormuz sanctions

    FTSE 100 Live
    Large cargo ship YEKTA S with NYK Logistics containers on turquoise water, SOUTH STAR SHIPPING visible.
  • Dunelm shares crater as hot weather undermines growth plan

    Retail
    Exterior of the new Dunelm Kingston superstore with a bright green facade and large glass windows.
  • IMU Biosciences and Eurofins Transplant Genomics Form Strategic Partnership to Advance Transplant-Related Clinical Development Programmes

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook